GI/endoscopy company stock report – Feb. 20, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for Feb. 13 to Feb. 20.   

Advertisement

•    AbbVie: $59.97 per share (up 1.64 percent)
•    Boston Scientific: $16.36  per share (down 0.52 percent)  
•    FUJIFILM Holdings: 4,002.50 per share (JPY) (down 0.2 percent)
•    Olympus: 4,280 per share (JPY) (up 0 percent)
•    Salix Pharmaceuticals: $157.75 per share (up 4.68 percent)

More articles on gastroenterology:
CRE infections at UCLA Medical Center transmitted during ERCP
What gastroenterologists can expect from a physician shortage
GI physician leader to know: Dr. Robynne Chutkan of Digestive Center for Women

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.